Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: A double-blind, clinical study

Drugs under Experimental and Clinical Research

Volumn 30, Issue 5-6, 2004, Pages 183-190

  Koller, Ján ^a,b  

^a Ruzinov Hospital   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; LALUGEN PLUS; SULFADIAZINE SILVER;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BURN; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; EDEMA; EPITHELIZATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PARTIAL THICKNESS BURN; RANDOMIZED CONTROLLED TRIAL; TOPICAL TREATMENT; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURNS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SILVER SULFADIAZINE;

EID: 11444270020     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fox C.L. Jr. Silver sulfadiazine: a new topical therapy for Pseudomonas in burns. Arch. Surg., 96S, 184, 1968.
2. Lindberg R.B., Moncrief J.A., Mason A.D. Jr. Control of experimental and clinical burn wound sepsis by topical application of sulfamylon compounds. Ann. N. Y. Acad. Sci., 150S, 950, 1968.
3. Carr H.S., Wlodokowski T.J., Rosenkranz H.S. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob. Ag. Chemother., 4(5) , 585, 1973.
4. Baars V.M., Opferkuch W., Müller F.E. In-vitro efficacy of topical antibiotics on bacteria from burns. Fortschr. Med., 98(11), 400, 1980 (in German).
5. Hoffmann S. Silver sulfadiazine: an antibacterial agent for topical use in burns. Scand. J. Plast. Reconstr Surg., 18, 119, 1984.
6. Dziewulski P. Burn wound healing. James Ellsworth Laing memorial essay for 1991. Burns, 18S, 104, 1992.
7. Loewi G. The acid mucopolysaccharides of human skin. Biochim. Biophy. Acta, 52, 435, 1961.
8. Rovee D.T., Kurowsky C.A., Labun J. Local wound environment and epidermal healing. Acta Derm., 106, 330, 1972.
9. Liguori V., Guillemin C., Pesce G.F., Mirimanoff R.O., Bernier J. Double-blind, randomized clinical study comparing cream to placebo in patients treated with radiotherapy. Radiother. Oncol., 42, 155, 1997.
10. Ortonne J.P. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J. Derm. Treat., 7, 75, 1996.
11. MacNeil S. What role does the extracellular matrix serve in skin grafting and wound healing? Burns, 20(Suppl. 1), S67, 1994.
12. Daniels J.T., Kearney J.N., Ingham E. An investigation into the potential of extracellular matrix factors for attachment and proliferation of human keratinocytes on skin substitutes. Burns, 23, 26, 1997.
13. Chen J.W.Y., Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen., 7, 79, 1999.
14. Asari A., Miyauchi S. Medical applications of hyaluronan. At: http://www.glycoforum.gr.jp//science/hyaluronan/HA12/HA12E.html, 2000.